Resveratrol, a dietary polyphenolic phytoalexin, is a functional scavenger of peroxynitrite

被引:129
作者
Holthoff, Joseph H. [1 ]
Woodling, Kellie A. [2 ]
Doerge, Daniel R. [2 ]
Burns, Samuel T. [1 ]
Hinson, Jack A. [1 ]
Mayeux, Philip R. [1 ]
机构
[1] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA
[2] US FDA, Div Biochem Toxicol, Natl Ctr Toxicol Res, Jefferson, AR USA
关键词
Resveratrol; Peroxynitrite; Nitration; SIN-1; Cytotoxicity; CISPLATIN-INDUCED NEPHROTOXICITY; NITROGEN SPECIES GENERATION; NITRIC-OXIDE; TYROSINE NITRATION; OXIDATIVE STRESS; IN-VIVO; INJURY; KIDNEY; ANTIOXIDANTS; DYSFUNCTION;
D O I
10.1016/j.bcp.2010.06.027
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Oxidant damage from reactive oxygen species (ROS) and reactive nitrogen species (RNS) is a major contributor to the cellular damage seen in numerous types of renal injury. Resveratrol (trans-3,4',5-trihydroxystilbene) is a phytoalexin found naturally in many common food sources. The anti-oxidant properties of resveratrol are of particular interest because of the fundamental role that oxidant damage plays in numerous forms of kidney injury. To examine whether resveratrol could block damage to the renal epithelial cell line, mIMCD-3, cells were exposed to the peroxynitrite donor 5-amino-3-(4-morpholinyl)-1,2,3-oxadiazolium chloride (SIN-1). Resveratrol produced a concentration-dependent inhibition of cytotoxicity induced by SIN-1. To examine the mechanism of protection, resveratrol was incubated with authentic peroxynitrite and found to block nitration of bovine serum albumin with an EC50 value of 22.7 mu M, in contrast to the known RNS scavenger, N-acetyl-L-cysteine, which inhibited nitration with an EC50 value of 439 mu M. These data suggested that resveratrol could provide functional protection by directly scavenging peroxynitrite. To examine whether resveratrol was a substrate for peroxynitrite oxidation, resveratrol was reacted with authentic peroxynitrite. Resveratrol nitration products and dimers were detected using liquid chromatograph with tandem electrospray mass spectrometry. Similar products were detected in the media of cells treated with SIN-1 and resveratrol. Taken collectively, the data suggest that resveratrol is able to provide functional protection of renal tubular cells, at least in part, by directly scavenging the RNS peroxynitrite. This property of resveratrol may contribute to the understanding of its anti-oxidant activities. (C) 2010 Elsevier Inc.Elsevier Inc. All rights reserved.
引用
收藏
页码:1260 / 1265
页数:6
相关论文
共 51 条
[1]
THE INFLUENCE OF EBSELEN ON THE TOXICITY OF CISPLATIN IN LLC-PK1 CELLS [J].
BALDEW, GS ;
BOYMANS, AP ;
MOL, JGJ ;
VERMEULEN, NPE .
BIOCHEMICAL PHARMACOLOGY, 1992, 44 (02) :382-387
[2]
New class of potent catalysts of O2.- dismutation.: Mn(III) ortho-methoxyethylpyridyl- and di-ortho-methoxyethyl-imidazolylporphyrins [J].
Batainic-Haberle, I ;
Spasojevic, I ;
Stevens, RD ;
Hambright, P ;
Neta, P ;
Okada-Matsumoto, A ;
Fridovich, I .
DALTON TRANSACTIONS, 2004, (11) :1696-1702
[3]
Therapeutic potential of resveratrol:: the in vivo evidence [J].
Baur, Joseph A. ;
Sinclair, David A. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) :493-506
[4]
APPARENT HYDROXYL RADICAL PRODUCTION BY PEROXYNITRITE - IMPLICATIONS FOR ENDOTHELIAL INJURY FROM NITRIC-OXIDE AND SUPEROXIDE [J].
BECKMAN, JS ;
BECKMAN, TW ;
CHEN, J ;
MARSHALL, PA ;
FREEMAN, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) :1620-1624
[6]
The interaction of resveratrol with ferrylmyoglobin and peroxynitrite; Protection against LDL oxidation [J].
Brito, P ;
Almeida, LM ;
Dinis, TCP .
FREE RADICAL RESEARCH, 2002, 36 (06) :621-631
[7]
Attenuation of oxidation and nitration reactions of peroxynitrite by selenomethionine, selenocystine and ebselen [J].
Briviba, K ;
Roussyn, I ;
Sharov, VS ;
Sies, H .
BIOCHEMICAL JOURNAL, 1996, 319 :13-15
[8]
Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen [J].
Brodsky, SV ;
Gealekman, O ;
Chen, J ;
Zhang, F ;
Togashi, N ;
Crabtree, M ;
Gross, SS ;
Nasjletti, A ;
Goligorsky, MS .
CIRCULATION RESEARCH, 2004, 94 (03) :377-384
[9]
Chirino Yolanda I., 2004, BMC Pharmacology, V4, P20, DOI 10.1186/1471-2210-4-20
[10]
Catalytic antioxidants to treat amyotropic lateral sclerosis [J].
Crow, John P. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (11) :1383-1393